Chris Scott Joins Perimeter Medical Imaging AI as CFO

Perimeter Medical Imaging AI Inc. has appointed Chris Scott as chief financial officer.

Scott brings to Perimeter his extensive experience in finance and accounting, as well as operations at a public medtech company. Before joining Perimeter, Scott was chief financial and operating officer at iRadimed Corporation since December 2013. Previously, he held a management position at Darden Restaurants Inc. from 2010 to 2013, where he provided accounting and reporting oversight. From 2002 to 2010, Scott served as an auditor and senior manager at KPMG LLP.

Scott earned a bachelor of science degree in accounting from the University of Central Florida in 2002.
 
“We are pleased to welcome Chris to the Perimeter leadership team. Chris is a collaborative leader who brings a wealth of public company experience directly relevant to Perimeter as we continue to execute on our commercial, clinical, and corporate development goals,” Perimeter CEO Jeremy Sobotta said. “Previously, Chris played a key role as chief financial and operating officer at a NASDAQ-listed medical device company, where he led them through an IPO process and subsequent scale-up during a period when their market cap grew from approximately $10 million pre-IPO to $600 million. Chris joins us at time when we have a strong balance sheet and see exciting milestones ahead, including the continued commercial launch of our flagship S-Series OCT and the ongoing development of our next-gen AI technology now being evaluated in a pivotal trial.”

In connection with his appointment, Scott has been issued 350,000 stock options pursuant to the company’s existing stock option plan and subject to TSX Venture Exchange acceptance. Each stock option is exercisable to purchase one common share of the company at $1.92 for a 10-year period from the grant date.
 
“I am excited to join Perimeter and their efforts to bring Perimeter’s ultra-high resolution medical imaging technology to market with the aim of improving patient outcomes and reducing healthcare costs,” Scott said. “Perimeter has many opportunities for growth, and I look forward to contributing to the advancement of this game-changing technology.”
  
Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI develops ultra-high-resolution, real-time, advanced imaging tools. Its U.S. Food and Drug Administration-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation, artificial intelligence technology that is currently under clinical development.